内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Viridian Therapeutics, Inc.\DE

VRDN · Nasdaq · CIK 0001590750 · Healthcare · Biotechnology

内部人信号

61.3 / 100

1 位买方 · 1 条买入交易行 · $20.0M 买入总额

为什么有这个信号？

买方广度较低
买入规模较强
角色较强
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+23.8 / 25
角色+20.0 / 20
近期性+0.7 / 10
确信度+9.8 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ 角色得分高 · 买入者中职位最高的是：Director,TenPercentOwner

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方1
买入集中度100%最大买方： Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P. · $20.0M
聚集买入 · 15天1 insider峰值活动： 2026-05-11–2026-05-11

Roles in the peak window: Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Tousignant JenniferChief Legal Officer
○▼
Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.Director,TenPercentOwner
●
Tripuraneni RadhikaChief Medical Officer
○
● 买入▼ 卖出○ 其他

—

信号历史

61.3 / 100

最新留档分数

↑ +0.1 pts相对上一个留档快照
  1. 61.3
  2. 61.3
  3. 61.3
  4. 61.2
  5. 61.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

2买入
3卖出
14其他 Form 4 交易行
13SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他2 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-16.3%
3M
-1.7%
6M
+24.8%
12M
-12.6%

波动率与流动性

波动率
64.8%
Beta
—
平均每日成交额
USD 32.1M

估值

市值
USD 2.1B
P/E
—

基本面

利润率
-483.6%
ROE
-47.4%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-03 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
17,965,668
上期报告
19,465,251
日均成交量
2,026,431
回补天数
8.9

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-05-11Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.买入 (P)Common Stock1,176,470USD 17.00USD 19,999,990SEC 申报 ↗
2025-10-23Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.买入 (P)Common Stock454,545USD 22.00USD 9,999,990SEC 申报 ↗
2024-09-27Mahoney Stephen F.买入 (P)Common Stock21,400USD 23.33USD 499,262SEC 申报 ↗
2024-09-27Beetham Thomas W.买入 (P)Common Stock5,000USD 23.41USD 117,050SEC 申报 ↗
2024-09-13Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.买入 (P)Common Stock1,600,000USD 18.75USD 30,000,000SEC 申报 ↗
2024-01-22Fairmount Funds Management LLC; Fairmount Healthcare Fund GP LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Fund L.P.买入 (P)Common Stock476,190USD 21.00USD 9,999,990SEC 申报 ↗
2023-04-12Myers Scott Dunseth买入 (P)Common Stock4,000USD 25.37USD 101,480SEC 申报 ↗
2023-03-13Myers Scott Dunseth买入 (P)Common Stock5,500USD 29.15USD 160,325SEC 申报 ↗
2022-08-17Fairmount Funds Management LLC; Fairmount Healthcare Fund GP LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Fund L.P.买入 (P)Common Stock425,531USD 23.50USD 9,999,978SEC 申报 ↗
2021-09-23FHMLSP, L.L.C.; FHMLSP, L.P.; Frazier Life Sciences Public Fund, L.P.买入 (P)Common Stock200,000USD 11.00USD 2,200,000SEC 申报 ↗
2021-09-21Fairmount Funds Management LLC; Fairmount Healthcare Fund GP LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Fund L.P.买入 (P)Common Stock909,000USD 11.00USD 9,999,000SEC 申报 ↗
2020-11-13Logos Global Master Fund LP买入 (P)Common Stock126,667USD 14.84USD 1,879,738SEC 申报 ↗
2020-11-09Logos Global Master Fund LP买入 (P)Common Stock350,000USD 1.12USD 391,000SEC 申报 ↗

Form 4 申报证据

19 transaction lines in the latest 365-day window; 88 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-19Tousignant Jennifer卖出 (S)Common Stock14,212USD 24.50USD 348,194SEC 申报 ↗
2026-08-19Tousignant Jennifer期权行权／转换 (M)Common Stock10,000USD 14.41USD 144,100SEC 申报 ↗
2026-08-14Tripuraneni Radhika期权行权／转换 (M)Common Stock40,000USD 13.21USD 528,400SEC 申报 ↗
展开近期 Form 4 证据 (18 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-19Tousignant Jennifer卖出 (S)Common Stock14,212USD 24.50USD 348,194SEC 申报 ↗
2026-08-19Tousignant Jennifer期权行权／转换 (M)Common Stock10,000USD 14.41USD 144,100SEC 申报 ↗
2026-08-14Tripuraneni Radhika期权行权／转换 (M)Common Stock40,000USD 13.21USD 528,400SEC 申报 ↗
2026-05-11Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.买入 (P)Common Stock1,176,470USD 17.00USD 19,999,990SEC 申报 ↗
2026-03-03Tousignant Jennifer代扣税 (F)Common Stock1,675USD 30.19USD 50,568SEC 申报 ↗
2026-03-03Mahoney Stephen F.代扣税 (F)Common Stock7,408USD 30.19USD 223,648SEC 申报 ↗
2026-03-03Harmon Seth代扣税 (F)Common Stock2,031USD 30.19USD 61,316SEC 申报 ↗
2026-03-03Beetham Thomas W.代扣税 (F)Common Stock3,048USD 30.19USD 92,019SEC 申报 ↗
2026-03-03Tousignant Jennifer期权行权／转换 (M)Common Stock5,169USD —USD —SEC 申报 ↗
2026-03-03Tousignant Jennifer代扣税 (F)Common Stock1,724USD 29.32USD 50,548SEC 申报 ↗
2026-03-03Mahoney Stephen F.期权行权／转换 (M)Common Stock18,357USD —USD —SEC 申报 ↗
2026-03-03Mahoney Stephen F.代扣税 (F)Common Stock7,627USD 29.32USD 223,624SEC 申报 ↗
2026-03-03Harmon Seth期权行权／转换 (M)Common Stock6,267USD —USD —SEC 申报 ↗
2026-03-03Harmon Seth代扣税 (F)Common Stock2,091USD 29.32USD 61,308SEC 申报 ↗
2026-03-03Beetham Thomas W.期权行权／转换 (M)Common Stock9,409USD —USD —SEC 申报 ↗
2026-03-03Beetham Thomas W.代扣税 (F)Common Stock3,138USD 29.32USD 92,006SEC 申报 ↗
2025-12-31Tousignant Jennifer卖出 (S)Common Stock2,272USD 31.16USD 70,796SEC 申报 ↗
2025-10-23Fairmount Funds Management LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.买入 (P)Common Stock454,545USD 22.00USD 9,999,990SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码VRDN
CIK0001590750
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史88 transaction lines from 2020-03-13 to 2026-08-19
14 P purchase lines · 32 S sale lines · 42 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.